Anti-Human VIM Therapeutic Antibody (2F6-1)
The monoclonal antibody specifically binds to human vimentin and can be potentially used in the treatment of cancers such as non-small cell lung cancer, pancreatic cancer and gastric cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-354CQ |
| Pricing | Inquiry |
| Applications | IF |
| Host | Mouse |
| Target | VIM (Vimentin) |
| Species Reactivity | Human |